Sandra Marmiroli Selected Research

Sandra Marmiroli Research Topics

Disease

10	Neoplasms (Cancer) 01/2020 - 12/2004
5	Leukemia 01/2021 - 02/2011
2	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 07/2022 - 02/2011
2	Lymphoma (Lymphomas) 09/2021 - 03/2019
2	Prostatic Neoplasms (Prostate Cancer) 01/2020 - 01/2019
2	Neuroblastoma 01/2016 - 07/2003
2	Laminopathies 01/2010 - 09/2009
2	Emery-Dreifuss Muscular Dystrophy (Scapuloperoneal Muscular Dystrophy) 11/2008 - 04/2003
2	Osteosarcoma (Osteogenic Sarcoma) 01/2006 - 03/2002
2	Necrosis 11/2003 - 07/2003
1	Genetic Predisposition to Disease (Genetic Predisposition) 12/2019
1	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 12/2019
1	Premature Aging 10/2018
1	Disease Progression 02/2016
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 02/2016
1	Breast Neoplasms (Breast Cancer) 01/2016
1	Blast Crisis (Blast Phase) 12/2015
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 12/2015
1	Myeloproliferative Disorders (Myeloproliferative Disorder) 12/2015
1	Lipodystrophy 09/2014
1	Duchenne Muscular Dystrophy (Muscular Dystrophy, Becker) 06/2013
1	Mitochondrial Diseases (Mitochondrial Disease) 06/2013
1	Melanoma (Melanoma, Malignant) 01/2013
1	Anemia 01/2013
1	Multiple Myeloma 07/2008
1	Acute Erythroblastic Leukemia (Erythroleukemia) 05/2002

Drug/Important Bio-Agent (IBA)

5	Lamin Type A (Lamin A)IBA 10/2018 - 04/2003
3	Proteins (Proteins, Gene)FDA Link 02/2011 - 11/2003
2	nutlin 3IBA 07/2022 - 02/2011
2	Dasatinib (BMS 354825)FDA Link 07/2022 - 02/2011
2	Phosphotransferases (Kinase)IBA 01/2020 - 11/2003
2	Phosphatidylinositols (Phosphatidylinositol)IBA 01/2020 - 01/2019
2	prelamin AIBA 10/2018 - 09/2014
2	TNF-Related Apoptosis-Inducing LigandIBA 02/2011 - 01/2006
2	TNF-Related Apoptosis-Inducing Ligand ReceptorsIBA 01/2006 - 07/2003
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 09/2021
1	MethyltransferasesIBA 01/2021
1	Hormones (Hormone)IBA 01/2020
1	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 01/2020
1	MTOR InhibitorsIBA 01/2020
1	AndrogensIBA 01/2020
1	TOR Serine-Threonine KinasesIBA 01/2020
1	SeleniumIBA 12/2019
1	ClusterinIBA 01/2019
1	Reactive Oxygen Species (Oxygen Radicals)IBA 10/2018
1	CateninsIBA 12/2016
1	Glycogen Synthase Kinase 3IBA 12/2016
1	ErbB Receptors (EGF Receptor)IBA 01/2016
1	Tyrosine Kinase InhibitorsIBA 12/2015
1	Oncogene Proteins (Oncogene Protein)IBA 12/2015
1	Biomarkers (Surrogate Marker)IBA 06/2013
1	DystrophinIBA 06/2013
1	Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA 01/2013
1	LipidsIBA 01/2013
1	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 01/2013
1	Fatty Acids (Saturated Fatty Acids)IBA 01/2013
1	Eicosanoic AcidsIBA 01/2013
1	Linoleic Acid (Linoleate)IBA 01/2013
1	docosapentaenoic acidIBA 01/2013
1	AntibodiesIBA 02/2011
1	LaminsIBA 01/2010
1	enzastaurinIBA 07/2008
1	Protein Kinase CIBA 07/2008
1	Protein Kinase C betaIBA 07/2008
1	Cisplatin (Platino)FDA LinkGeneric 01/2006
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2006
1	Death Domain ReceptorsIBA 01/2006
1	Antineoplastic Agents (Antineoplastics)IBA 01/2006
1	MutagensIBA 01/2006
1	CytokinesIBA 12/2004
1	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 12/2004
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 12/2004
1	Interleukin-1 (Interleukin 1)IBA 11/2003
1	NF-kappa B (NF-kB)IBA 11/2003
1	LigandsIBA 07/2003
1	emerinIBA 04/2003
1	Type C PhospholipasesIBA 05/2002
1	Phospholipase C betaIBA 05/2002
1	Troglitazone (Rezulin)FDA Link 03/2002
1	PPAR-gamma AgonistsIBA 03/2002
1	PPAR gammaIBA 03/2002

Therapy/Procedure

11	Therapeutics 09/2020 - 01/2006
2	Castration 01/2020 - 01/2019
1	Radiotherapy 01/2019
1	Drug Therapy (Chemotherapy) 01/2006